Abbott India Limited (ABBOTINDIA.NS)

INR 30495.0

(-1.68%)

Total Debt Summary of Abbott India Limited

Abbott India Limited's latest annual total debt in 2023 was 832.3 Million INR , down -26.46% from previous year.
Abbott India Limited's latest quarterly total debt in 2023 FY was 832.3 Million INR , down -26.46% from previous quarter.
Abbott India Limited reported annual total debt of 1.13 Billion INR in 2022, down -25.39% from previous year.
Abbott India Limited reported annual total debt of 1.51 Billion INR in 2021, down -0.58% from previous year.
Abbott India Limited reported quarterly total debt of - INR for 2023 Q3, down -100.0% from previous quarter.
Abbott India Limited reported quarterly total debt of 915.4 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Abbott India Limited (2023 - 2004)

Historical Annual Total Debt of Abbott India Limited (2023 - 2004)

Year	Total Debt	Total Debt Growth
2023	832.3 Million INR	-26.46%
2022	1.13 Billion INR	-25.39%
2021	1.51 Billion INR	-0.58%
2020	1.52 Billion INR	-12.76%
2019	1.74 Billion INR	0.0%
2018	- INR	0.0%
2017	- INR	0.0%
2016	- INR	0.0%
2015	- INR	0.0%
2014	- INR	0.0%
2013	- INR	0.0%
2012	- INR	0.0%
2011	- INR	0.0%
2010	- INR	0.0%
2009	- INR	-100.0%
2008	7.6 Million INR	-26.21%
2007	10.3 Million INR	-26.95%
2006	14.1 Million INR	-22.53%
2005	18.2 Million INR	-16.89%
2004	21.9 Million INR	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	832.3 Million INR	-26.46%
2023 Q3	- INR	-100.0%
2023 Q2	915.4 Million INR	0.0%
2023 Q4	832.3 Million INR	0.0%
2023 Q1	- INR	-100.0%
2022 Q4	1.13 Billion INR	0.0%
2022 Q2	1.28 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 FY	1.13 Billion INR	-25.39%
2022 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q4	1.51 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 FY	1.51 Billion INR	-0.58%
2021 Q2	1.61 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2020 FY	1.52 Billion INR	-12.76%
2020 Q1	- INR	-100.0%
2020 Q4	1.52 Billion INR	0.0%
2020 Q2	1.66 Billion INR	0.0%
2019 Q4	1.74 Billion INR	0.0%
2019 FY	1.74 Billion INR	0.0%
2019 Q1	- INR	0.0%
2019 Q2	507.5 Million INR	0.0%
2019 Q3	- INR	-100.0%
2018 Q2	- INR	0.0%
2018 FY	- INR	0.0%
2018 Q3	- INR	0.0%
2018 Q1	- INR	0.0%
2018 Q4	- INR	0.0%
2017 Q3	- INR	0.0%
2017 Q2	- INR	0.0%
2017 Q1	- INR	0.0%
2017 FY	- INR	0.0%
2017 Q4	- INR	0.0%
2016 Q2	- INR	0.0%
2016 Q4	- INR	0.0%
2016 Q1	- INR	0.0%
2016 FY	- INR	0.0%
2016 Q3	- INR	0.0%
2015 FY	- INR	0.0%
2015 Q2	- INR	0.0%
2015 Q3	- INR	0.0%
2015 Q4	- INR	0.0%
2015 Q1	- INR	0.0%
2014 Q4	- INR	0.0%
2014 Q1	- INR	0.0%
2014 FY	- INR	0.0%
2014 Q2	- INR	0.0%
2014 Q3	- INR	0.0%
2013 FY	- INR	0.0%
2013 Q4	- INR	0.0%
2013 Q2	- INR	0.0%
2013 Q1	- INR	0.0%
2012 Q3	- INR	0.0%
2012 Q4	- INR	0.0%
2012 FY	- INR	0.0%
2011 Q3	- INR	0.0%
2011 FY	- INR	0.0%
2010 FY	- INR	0.0%
2009 FY	- INR	-100.0%
2008 FY	7.6 Million INR	-26.21%
2007 FY	10.3 Million INR	-26.95%
2006 FY	14.1 Million INR	-22.53%
2005 FY	18.2 Million INR	-16.89%
2004 FY	21.9 Million INR	0.0%

Peer Total Debt Comparison of Abbott India Limited

Name	Total Debt	Total Debt Difference
Cipla Limited	5.59 Billion INR	85.122%
Gland Pharma Limited	3.72 Billion INR	77.636%
GlaxoSmithKline Pharmaceuticals Limited	186.65 Million INR	-345.915%
Kopran Limited	992.28 Million INR	16.123%
Marksans Pharma Limited	2.44 Billion INR	65.898%
NGL Fine-Chem Limited	324.42 Million INR	-156.547%
Pfizer Limited	945.4 Million INR	11.963%
Sanofi India Limited	190 Million INR	-338.053%
SMS Pharmaceuticals Limited	2.8 Billion INR	70.357%
TTK Healthcare Limited	228.1 Million INR	-264.874%